About this ingredient
Ingredients
NMNH (Reduced Nicotinamide Mononucleotide) is the reduced form of nicotinamide mononucleotide (NMN) and a recently studied compound involved in NAD⁺ metabolism. Research has identified NMNH as a potential NAD⁺ precursor that may contribute to increasing cellular NAD⁺ levels.
NMNH is chemically related to NMN but has a different redox state. The exact purity, stability, amount, formulation, and additional ingredients can vary between products and manufacturers. Because NMNH is a newer nutritional ingredient, consumers should check the specific product label and manufacturer information carefully.
NMNH, short for Reduced Nicotinamide Mononucleotide, is a reduced form of NMN that has attracted scientific interest as a potential NAD⁺ precursor. NAD⁺ is an essential coenzyme involved in cellular energy metabolism, redox reactions, and numerous enzyme-dependent biological processes.
Research published in Nature Metabolism identified NMNH as a reduced NAD⁺ precursor and reported that it could increase NAD⁺ levels in mammalian cells and mice. These findings have generated interest in NMNH as a potential alternative approach to supporting NAD⁺ metabolism.
However, NMNH is at an earlier stage of research than conventional NMN. Human clinical evidence regarding NMNH supplementation, long-term safety, appropriate dosing, and broader health outcomes remains limited. This is an important distinction from NMN, for which multiple human trials and recent systematic reviews are available.
NMNH may be included in specialized NAD⁺-support, cellular-energy, healthy-aging, and advanced nutritional formulations. The exact formulation can differ substantially between products, so check the label for NMNH content, purity, stability information, serving size, and additional ingredients.